Abstract:P1009 Purpose: We have previously demonstrated that targeting both dendritic cells and T cells simultaneously achieved reliable tolerance in a mouse transplant model, which depended on a regulatory feedback loop (J Immunol 2003, 170:1304) between tolerogenic dendritic cells (Tol-DC) and T regulatory cells (Treg). The present study was undertaken to determine if there is synergy in the induction of tolerance by simultaneous adoptive transfer of Tol-DC and Treg. Methods: BALB/c mice receiving C57BL/6 cardiac allografts were treated with LF 15-0195, a novel analogue of 15-deoxysperqualine at dose of 2 mg/kg for 20 days and long-term survivors (>100 days) were defined as tolerant recipients. CD11c+ dendritic cells, CD4+CD25+ and CD8+CD28- Treg cells were isolated from spleens of tolerant recipients. Tol-DC alone (5x106/mouse), Treg alone (1x106/mouse) or a combination of Tol-DC and Treg were intravenously injected into naive BALB/c recipients prior to and/or after allogeneic (C57/BL6->Balb/c) transplantation. The recipients received sublethal radiation and no additional immunosuppressants were used. Results: The Tol-DC isolated from tolerant recipients demonstrated immature phenotypes, impaired antigen presenting function, and inhibited allostimulatory capacity. Adoptive transfer of Tol-DC significantly prolonged allograft survival to a median survival time (MST) of 38 days, while recipients without transfer survived to MST of 13 days. On the other hand, CD4+CD25+ and CD8+CD28- T cell subsets were significantly increased in tolerant recipients as compared with rejecting recipients and non-transplanted mice. Both ex vivo isolated CD4+CD25+ and CD8+CD28- T cells potently suppressed ongoing MLR in vitro, suggesting they possess Treg function. Furthermore, both Treg subsets synergized with Tol-DC in the induction of tolerance. Adoptive transfer of a combination of Tol-DC and a subtherapeutic dose of either CD4+CD25+ or CD8+CD28- Treg significantly prolonged survival to MST of 85 days (P<0.05) and MST of 105 days (P<0.01), respectively. Conclusions: This study provides the first direct evidence that Tol-DC synergize with Treg in the induction of transplant tolerance. These findings shed light on mechanisms of tolerance induction through the regulatory feedback loop between Tol-DC and Treg.

Tolerogenic Dendritic Cells Generated by RelB Silencing Using Shrna Prevent Acute Rejection.

Prevention of Acute Rejection by RelB Sirna-Silenced Dendritic Cells

Preventing Immune Rejection Through Gene Silencing.

Immune Modulation And Tolerance Induction By Relb-Silenced Dendritic Cells Through Rna Interference

Lentiviral-mediated Shrna Against RelB Induces the Generation of Tolerogenic Dendritic Cells.

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Lentiviral-mediated Short Hairpin RNA Against RelB Produces the Generation of Tolerogenic Dendritic Cells

Effects of Tolerogenic Dendritic Cells Generated by Sirna-Mediated RelB Silencing on Immune Defense and Surveillance Functions of T Cells.

Prevention of Allograft Rejection by in Vitro Generated Tolerogenic Dendritic Cells

Tolerogenic Dendritic Cells Transferring Hyporesponsiveness and Synergizing T Regulatory Cells in Transplant Tolerance

Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble Tnf Receptor

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

Dendritic Cells Transduced with Lentiviral Vector Targeting RelB Gene Using RNA Interference Induce Hyporesponsiveness in Memory CD4(+) T Cells and Naïve CD4(+) T Cells.

Retinoic acid-inducible gene-1 knockdown induces immature properties in dendritic cells and prolongs the survival time of allograft mice

Inhibitory Feedback Loop Between Tolerogenic Dendritic Cells and Regulatory T Cells in Transplant Tolerance

Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.

CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

SYNERGISTIC TOLERANCE BY ADOPTIVE TRANSFER OF TOLEROGENIC DENDRITIC CELLS AND T REGULATORY CELLS:

[Effect of RelB-silenced BMDC pulsed with Talpha146~162 on immunoreaction of T cells primed with TAChR].

PU.1-silenced Dendritic Cells Prolong Allograft Survival in Rats Receiving Intestinal Transplantation.

A Role for Anti-Cd45rb Monoclonal Antibody Treatment Upon Dendritic Cells.